Inventor · disambiguated record
Ernst Schönbrunn
Also filed as: SCHONBRUNN ERNST · SCHÖNBRUNN ERNST
9 granted patents·5 pending applications·9 citations·filing 2012–2023
80Inventor score
Top patents by PatentIndex Score
14 records- 0187US9597329B2Aurora kinase inhibitors and methods of making and using thereofSEBTI SAID M·Filed 2016·Granted Mar 21, 2017·4 cites·12 claims
- 0285US10526291B2Potent dual BRD4-kinase inhibitors as cancer therapeuticsH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Jan 7, 2020·2 cites·33 claims
- 0371US9808447B2Inhibitors of Rho associated protein kinases (ROCK) and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Nov 7, 2017·1 cites·21 claims
- 0469US9409868B2Inhibitors of rho associated protein kinases (ROCK) and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2013·Granted Aug 9, 2016·1 cites·5 claims
- 0568US9249124B2Aurora kinase inhibitors and methods of making and using thereofSEBTI SAID M·Filed 2012·Granted Feb 2, 2016·1 cites·6 claims
- 0662US11643396B2BRD4-kinase inhibitors as cancer therapeuticsH LEE MOFFITT CANCER CT & RES·Filed 2020·Granted May 9, 2023·0 cites·10 claims
- 0762US2024002339A1Therapeutic compounds and methodsUNIV MINNESOTA·Filed 2023·Application pending·0 cites
- 0861US12391676B2BRD4-JAK2 inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Aug 19, 2025·0 cites·10 claims
- 0960US12187686B2BRD4-JAK2 inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Jan 7, 2025·0 cites·8 claims
- 1057US10738016B2BRD4-kinase inhibitors as cancer therapeuticsH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Aug 11, 2020·0 cites·15 claims
- 1156US2024140952A1Inhibitors and degraders of janus kinase 2H LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 1251US2024398800A1Compounds for targeted degradation of taf1H LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 1346US2024002378A1Merged scaffold taf1 inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 1442US2024150333A1Taf1 inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →